Xi'an Greday Biological Technology Officially Registered, Anchored in API Export and Pharmaceutical CDMO
Xi'an Greday Biological Technology (Xi'an Greday Biological Technology) has recently completed business registration in Xi'an. Positioned around high-quality API export, customized CDMO API contract manufacturing, and injectable OEM production, the company is rooted in Shaanxi while building a global pharmaceutical supply chain business. In its founding stage, it deeply engaged pharmaceutical research resources in Northwest China and university-enterprise joint laboratories, establishing three foundational systems — API sourcing, quality testing, and export documentation compliance — laying a solid foundation for global expansion.
Xi’an Greday Biological Technology has recently completed business registration in Xi’an. Positioned around high-quality API export, customized CDMO API contract manufacturing, and injectable OEM production, the company is rooted in Shaanxi while building a global pharmaceutical supply chain business.
Three Core Businesses, One Integrated Pharmaceutical Supply Chain
From day one, Xi’an Greday Biological Technology set a differentiated path built around three business pillars:
- High-quality API export — Leveraging established export qualifications and a robust quality system to supply clinically essential injectable APIs to essential medicine markets such as Southeast Asia and the Middle East;
- Customized CDMO API manufacturing — Deep engagement with pharmaceutical research resources in Northwest China and university-enterprise joint laboratories, undertaking process development and custom synthesis of high-value APIs such as peptides and amino acids;
- Injectable OEM production — Completing formulation contract-manufacturing registration documentation in parallel, supporting overseas pharma companies and hospital pharmacies with end-to-end production from API to finished product.
Three Foundational Systems, a Solid Base for Globalization
In its founding stage, the company prioritized three foundational systems — API sourcing, quality testing, and export documentation compliance — ensuring end-to-end stability and control from sourcing and quality assurance to export compliance. We first focused on mature categories such as clinically essential injectable APIs, deepening our presence in Southeast Asian and Middle Eastern essential medicine markets while steadily validating the full export workflow.
Looking ahead, Xi’an Greday Biological Technology will stay committed to the principle of “R&D-driven, quality-first, compliant globalization,” continuously upgrading toward high-value specialty APIs and innovative-drug CDMO, and contributing Chinese manufacturing strength to the global pharmaceutical supply chain.
Welcome to contact us to discuss API supply and contract manufacturing cooperation.